Clinical efficacy and safety evaluation of New Tiaoxin Decoction in the treatment of Mild Cognitive Impairment

Phase 1

• Conditions: Mild Cognitive Impairment

• Registration Number: ITMCTR2000003591
• Lead Sponsor: Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

reference resource Guidelines for clinical research of Mild Cognitive Impairment (Draft) (2008 Edition)

Exclusion Criteria

reference resource Guidelines for clinical research of mild cognitive impairment (Draft) (2008 Edition)

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Montreal cognitive assessment,MoCA;mini-mental state examination,MMSE;

Secondary Outcome Measures

Name	Time	Method
Alzheimer disease assessment scale-cog, ADAS-cog;Activities of Daily Living, ADL;The Neuropsychiatric Inventory, NPI;Wechsler memory scale-Revised, WMS-R;